Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Coronavirus disease 2019 (Covid-19) has been declared global emergency with immediate safety, preventative and curative measures to control the spread of virus. Confirmed cases are treated with clinical management as they are diagnosed but so far, there is no effective treatment or vaccine yet for Covid-19. With recommended guidelines of AYUSH Ministry, India, the use of Ayurveda for Covid-19 has increased; however, its efficacy and safety in Covid-19 confirmed patients remain unclear. Present study examined the efficacy and safety of one of the recommended Ayurveda drug (Guduchi Ghan Vati) compared with standard care for patients with asymptomatic Covid-19 patients.
Description: Virologic clearance indicates the duration from the first Covid‐19 positive result to the first Covid-19 negative result
Measure: Virologic clearance Time: 21 daysDescription: change in the number of patients going from asymptomatic to moderately disease
Measure: Change in the number of patients going from asymptomatic to moderately disease Time: 10-days of hospital admissionDescription: Total duration of stay in hospital for complete recovery
Measure: Hospital Stay Time: 21 daysDescription: Clinically relevant adverse effects of Guduchi Ghan Vati (Disability, Discomfort reported)
Measure: Clinically relevant adverse effects Time: 21-days